Author Question: The therapeutic action of monoamine oxidase inhibitors (MAOIs) blocks neurotransmitter reuptake, ... (Read 70 times)

robinn137 · **on:** Jul 19, 2018

The therapeutic action of monoamine oxidase inhibitors (MAOIs) blocks neurotransmitter reuptake, causing:

a. increased concentration of neurotransmitters in the synaptic gap
b. decreased concentration of neurotransmitters in serum
c. destruction of receptor sites
d. limbic system stimulation

Question 2

A patient taking medication for mental illness develops restlessness and an uncontrollable need to be in motion. A nurse can correctly analyze that these symptoms are related to which drug action?

a. Anticholinergic effects
b. Dopamine-blocking effects
c. Endocrine-stimulating effects
d. Ability to stimulate spinal nerves

dantucker · **Reply #1 on:** Jul 19, 2018

Answer to Question 1

ANS: A
If the reuptake of a substance is inhibited, then it accumulates in the synaptic gap and its concentration increases, permitting the ease of the transmission of impulses across the synaptic gap. Normal transmission of impulses across synaptic gaps is consistent with a normal rather than a depressed mood. The other options are not associated with blocking neurotransmitter reuptake.

Answer to Question 2

ANS: B
Medications that block dopamine often produce disturbances of movement such as akathisia because dopamine affects neurons involved in both the thought processes and movement regulation. Anticholinergic effects include dry mouth, blurred vision, urinary retention, and constipation. Akathisia is not caused by endocrine stimulation or spinal nerve stimulation.